Cargando…
Decreased Serum Dickkopf-1 Levels After Hypoglycemic Therapy in Patients with Type 2 Diabetes Mellitus
AIM: Dickkopf-1 (DKK-1) is a major inhibitor of Wingless protein signaling pathway, which is involved in glucose metabolism and cardiovascular diseases. The aim of the study was to investigate the changes of serum DKK-1 levels after hypoglycemic treatments and the relationship between DKK-1 and clin...
Autores principales: | Gao, Fei, Li, Cheng, Peng, Jiahui, Lu, Wei, Zhu, Wei, Zhou, Jian, Lu, Jingyi, Ma, Xiaojing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462435/ https://www.ncbi.nlm.nih.gov/pubmed/36091484 http://dx.doi.org/10.2147/DMSO.S376988 |
Ejemplares similares
-
Serum 1,5-Anhydroglucitol to Glycated Albumin Ratio Can Help Early Distinguish Fulminant Type 1 Diabetes Mellitus from Newly Onset Type 1A Diabetes Mellitus
por: Ying, Lingwen, et al.
Publicado: (2020) -
Decreased Circulating Levels of Dickkopf-1 in Patients with Exudative Age-related Macular Degeneration
por: Qiu, Fangfang, et al.
Publicado: (2017) -
Relationship between serum Dickkopf-1 and albuminuria in patients with type 2 diabetes
por: Hou, Ning-Ning, et al.
Publicado: (2021) -
Growth differentiation factor 15 is not associated with glycemic control in patients with type 2 diabetes mellitus treated with metformin: a post-hoc analysis of AIM study
por: Gao, Fei, et al.
Publicado: (2022) -
A Novel CGM Metric-Gradient and Combining Mean Sensor Glucose Enable to Improve the Prediction of Nocturnal Hypoglycemic Events in Patients with Diabetes
por: Li, Jingzhen, et al.
Publicado: (2020)